Reunion Neuroscience Inc

NASDAQ:REUN   3:59:54 PM EDT
1.60
-0.12 (-6.98%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)18.61M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.85 Million
Adjusted EPS-$0.27
See more estimates
10-Day MA$1.72
50-Day MA$3.20
200-Day MA$5.87
See more pivots

Reunion Neuroscience Inc Stock, NASDAQ:REUN

30 Duncan Street, Lower North Suite, Toronto, Ontario M5V 2C3
Phone: +1.833.833.1967
Number of Employees: 194

Description

Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada.